Acrinova Ab Series Stock Fundamentals

ACRI-B Stock  SEK 9.18  0.08  0.86%   
Acrinova AB Series fundamentals help investors to digest information that contributes to Acrinova's financial success or failures. It also enables traders to predict the movement of Acrinova Stock. The fundamental analysis module provides a way to measure Acrinova's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acrinova stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Acrinova AB Series Company Current Valuation Analysis

Acrinova's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Acrinova Current Valuation

    
  1.41 B  
Most of Acrinova's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acrinova AB Series is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Acrinova AB Series has a Current Valuation of 1.41 B. This is 90.72% lower than that of the Real Estate sector and significantly higher than that of the Real Estate—Diversified industry. The current valuation for all Sweden stocks is 91.53% higher than that of the company.

Acrinova AB Series Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Acrinova's current stock value. Our valuation model uses many indicators to compare Acrinova value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acrinova competition to find correlations between indicators driving Acrinova's intrinsic value. More Info.
Acrinova AB Series is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.14  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Acrinova AB Series is roughly  6.94 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acrinova by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acrinova's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Acrinova Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acrinova's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acrinova could also be used in its relative valuation, which is a method of valuing Acrinova by comparing valuation metrics of similar companies.
Acrinova is currently under evaluation in current valuation category among its peers.

Acrinova Fundamentals

About Acrinova Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Acrinova AB Series's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acrinova using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acrinova AB Series based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Acrinova AB owns, develops, and manages real estate properties in southern Sweden. The company was founded in 2014 and is headquartered in Malm, Sweden. Acrinova is traded on Stockholm Stock Exchange in Sweden.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Acrinova Stock

Acrinova financial ratios help investors to determine whether Acrinova Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acrinova with respect to the benefits of owning Acrinova security.